Epidemiology of primary open angle glaucoma

Glaucoma Identification and Co-management

Volumn , Issue , 2007, Pages 1-16

  Rudnicka, Alicja ^a   Owen, Christopher G ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882511080     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7506-3782-4.50004-1     Document Type: Chapter

References (113)

1. Wald NJ The Epidemiological Approach: An Introduction to Epidemiology in Medicine 2004, Royal Society of Medicine Press, London.
2. Coleman AL Glaucoma. Lancet 1999, 354:1803-1810.
3. Kitazawa Y, Horie T, Aoki S, et al. Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol 1977, 95:1180-1184.
4. David R, Livingston DG, Luntz MH Ocular hypertension-a long-term follow-up of treated and untreated patients. Br J Ophthalmol 1977, 61:668-674.
5. Quigley HA, Enger C, Katz J, et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 1994, 112:644-649.
6. Leske MC, Connell AM, Wu SY, et al. Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Arch Ophthalmol 2001, 119:89-95.
7. Le A, Mukesh BN, McCarty CA, et al. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003, 44:3783-3789.
8. Congdon N, Wang F, Tielsch JM Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv Ophthalmol 1992, 36:411-423.
9. Bengtsson B The prevalence of glaucoma. Br J Ophthalmol 1981, 65:46-49.
10. Coffey M, Reidy A, Wormald R, et al. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 1993, 77:17-21.
11. Tielsch JM, Sommer A, Witt K, et al. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol 1990, 108:286-290.
12. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991, 266:369-374.
13. Hollows FC, Graham PA Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 1966, 50:570-586.
14. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989, 96:1363-1368.
15. Leske MC, Connell AM, Schachat AP, et al. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994, 112:821-829.
16. Wormald RP, Basauri E, Wright LA, et al. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye 1994, 8(Pt 3):315-320.
17. Buhrmann RR, Quigley HA, Barron Y, et al. Prevalence of glaucoma in a rural East African population. Invest Ophthalmol Vis Sci 2000, 41:40-48.
18. Rotchford AP, Kirwan JF, Muller MA, et al. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology 2003, 110:376-382.
19. Awasthi P, Sarbhai KP, Banerjee SC, et al. Prevalence study of glaucoma in rural areas. Indian J Ophthalmol 1975, 23:1-5.
20. Hu CN An epidemiologic study of glaucoma in Shunyi County, Beijing. Zhonghua Yan Ke Za Zhi 1989, 25:115-119.
21. Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glaucoma in Japan-a nationwide glaucoma survey. Jpn J Ophthalmol 1991, 35:133-155.
22. Foster PJ, Baasanhu J, Alsbirk PH, et al. Glaucoma in Mongolia. A population-based survey in Hovsgol province, northern Mongolia. Arch Ophthalmol 1996, 114:1235-1241.
23. Jacob A, Thomas R, Koshi SP, et al. Prevalence of primary glaucoma in an urban south Indian population. Indian J Ophthalmol 1998, 46:81-86.
24. Foster PJ, Oen FTS, Machin D, et al. The prevalence of glaucoma in Chinese residents of Singapore-A cross-sectional population survey of the Tanjong Pagar District. Arch Ophthalmol 2000, 118:1105-1111.
25. Metheetrairut A, Singalavanija A, Ruangvaravate N, et al. Evaluation of screening tests and prevalence of glaucoma: integrated health research program for the Thai elderly. J Med Assoc Thai 2002, 85:147-153.
26. Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology 2003, 110:1484-1490.
27. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004, 111:1641-1648.
28. Arkell SM, Lightman DA, Sommer A, et al. The prevalence of glaucoma among Eskimos of northwest Alaska. Arch Ophthalmol 1987, 105:482-485.
29. Bankes JL, Perkins ES, Tsolakis S, et al. Bedford glaucoma survey. Br Med J 1968, 1:791-796.
30. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980, 24:335-610.
31. Ringvold A, Blika S, Elsas T, et al. The middle-Norway eye-screening study. II. Prevalence of simple and capsular glaucoma. Acta Ophthalmol (Copenhagen) 1991, 69:273-280.
32. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992, 99:1499-1504.
33. Salmon JF, Mermoud A, Ivey A, et al. The prevalence of primary angle closure glaucoma and open angle glaucoma in Mamre, Western Cape, South Africa. Arch Ophthalmol 1993, 111:1263-1269.
34. Dielemans I, Vingerling JR, Wolfs RC, et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 1994, 101:1851-1855.
35. Giuffre G, Giammanco R, Dardanoni G, et al. Prevalence of glaucoma and distribution of intraocular pressure in a population. The Casteldaccia Eye Study. Acta Ophthalmol Scand 1995, 73:222-225.
36. Hirvela H, Tuulonen A, Laatikainen L Intraocular pressure and prevalence of glaucoma in elderly people in Finland: a population-based study. Int Ophthalmol 1994, 18:299-307.
37. Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996, 103:1661-1669.
38. Cedrone C, Culasso F, Cesareo M, et al. Prevalence of glaucoma in Ponza, Italy: a comparison with other studies. Ophthalmic Epidemiol 1997, 4:59-72.
39. Wensor MD, McCarty CA, Stanislavsky YL, et al. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998, 105:733-739.
40. Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 1998, 105:209-215.
41. Reidy A, Minassian DC, Vafidis G, et al. Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study. BMJ 1998, 316:1643-1646.
42. Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 2001, 119:1819-1826.
43. Mann I, Potter D Geographic ophthalmology. A preliminary study of the Maoris of New Zealand. Am J Ophthalmol 1969, 67:358-369.
44. Taylor HR Prevalence and causes of blindness in Australian aborigines. Med J Aust 1980, 1:71-76.
45. Rudnicka AR, Mt-Isa S, Owen CG, et al. Variations in primary open angle glaucoma prevalence by age, gender and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 2006, 47:4254-4261.
46. Bengtsson BO Incidence of manifest glaucoma. Br J Ophthalmol 1989, 73:483-487.
47. Dreyer EB, Lipton SA New perspectives on glaucoma. JAMA 1999, 281:306-308.
48. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991, 109:1090-1095.
49. Klein BE, Klein R, Linton KL Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1992, 33:2224-2228.
50. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000, 107:1287-1293.
51. Mitchell P, Hourihan F, Sandbach J, et al. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999, 106:2010-2015.
52. Wong TY, Klein BE, Klein R, et al. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology 2003, 110:211-217.
53. Grodum K, Heijl A, Bengtsson B Refractive error and glaucoma. Acta Ophthalmol Scand 2001, 79:560-566.
54. Wu SY, Nemesure B, Leske MC Refractive errors in a black adult population: the Barbados Eye Study. Invest Ophthalmol Vis Sci 1999, 40:2179-2184.
55. Leske MC, Nemesure B, He Q, et al. Patterns of open-angle glaucoma in the Barbados Family Study. Ophthalmology 2001, 108:1015-1022.
56. Schoff EO, Hattenhauer MG, Ing HH, et al. Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota. Ophthalmology 2001, 108:882-886.
57. Mukesh BN, McCarty CA, Rait JL, et al. Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 2002, 109:1047-1051.
58. Owen CG, Carey IM, De Wilde S, et al. The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003. Br J Ophthalmol 2006, 90:861-868.
59. Wormald R, Fraser S, Bunce C Time to look again at sight tests. BMJ 1997, 314:245.
60. Fraser S, Bunce C, Wormald R, et al. Deprivation and late presentation of glaucoma: case-control study. BMJ 2001, 322:639-643.
61. Fraser S, Bunce C, Wormald R Retrospective analysis of risk factors for late presentation of chronic glaucoma. Br J Ophthalmol 1999, 83:24-28.
62. Tielsch JM, Sommer A, Katz J, et al. Socioeconomic status and visual impairment among urban Americans. Baltimore Eye Survey Research Group. Arch Ophthalmol 1991, 109:637-641.
63. Klein BE, Klein R, Rtter LL Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Eye Study. Ophthalmology 1993, 100:1609-1613.
64. Bonovas S, Filioussi K, Tsantes A, et al. Epidemiological association between cigarette smoking and primary open-angle glaucoma: a meta-analysis. Public Health 2004, 118:256-261.
65. Gottfredsdottir MS, Sverrisson T, Musch DC, et al. Chronic open-angle glaucoma and associated ophthalmic findings in monozygotic twins and their spouses in Iceland. J Glaucoma 1999, 8:134-139.
66. Mitchell P, Rochtchina E, Lee AJ, et al. Bias in self-reported family history and relationship to glaucoma: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2002, 9:333-345.
67. Weih LM, Mukesh BN, McCarty CA, et al. Association of demographic, familial, medical, and ocular factors with intraocular pressure. Arch Ophthalmol 2001, 119:875-880.
68. Nemesure B, Leske MC, He Q, et al. Analyses of reported family history of glaucoma: a preliminary investigation. The Barbados Eye Study Group. Ophthalmic Epidemiol 1996, 3:135-141.
69. Tielsch JM, Katz J, Sommer A, et al. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994, 112:69-73.
70. Wolfs RC, Klaver CC, Ramrattan RS, et al. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol 1998, 116:1640-1645.
71. Quigley HA Open-angle glaucoma. N Engl J Med 1993, 328:1097-1106.
72. Weisschuh N, Schiefer U Progress in the genetics of glaucoma. Dev Ophthalmol 2003, 37:83-93.
73. Challa P Glaucoma genetics: advancing new understandings of glaucoma pathogenesis. Int Ophthalmol Clin 2004, 44:167-185.
74. Cohen CS, Allingham RR The dawn of genetic testing for glaucoma. Curr Opin Ophthalmol 2004, 15:75-79.
75. Morgan RW, Drance SM Chronic open-angle glaucoma and ocular hypertension. An epidemiological study. Br J Ophthalmol 1975, 59:211-215.
76. Leske MC, Podgor MJ Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol 1983, 118:280-287.
77. Wilson MR, Hertzmark E, Walker AM, et al. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol 1987, 105:1066-1071.
78. Dielemans I, Vingerling JR, Algra D, et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995, 102:54-60.
79. Tielsch JM, Katz J, Sommer A, et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995, 113:216-221.
80. Graham S Are vascular factors involved in glaucomatous damage?. Aust N Z J Ophthalmol 1999, 27:354-356.
81. Laatikainen L Fluorescein angiographic studies of the peripapillary and perilimbal regions in simple, capsular and low-tension glaucoma. Acta Ophthalmol Suppl 1971, 111:3-83.
82. Mitchell P, Smith W, Chey T, et al. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997, 104:712-718.
83. Tielsch JM, Katz J, Quigley HA, et al. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995, 102:48-53.
84. Flammer J, Haefliger IO, Orgul S, et al. Vascular dysregulation: a principal risk factor for glaucomatous damage?. J Glaucoma 1999, 8:212-219.
85. Goldberg I, Hollows FC, Kass MA, et al. Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol 1981, 65:56-62.
86. Chisholm IA, Stead S Plasma lipid patterns in patients with suspected glaucoma. Can J Ophthalmol 1988, 23:164-167.
87. Goldberg I Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy. Br J Ophthalmol 2002, 86:691-692.
88. Stewart WC, Osterman J Serum lipid physiology and the influence of glaucoma medications. Surv Ophthalmol 1998, 43:233-244.
89. Mitchell P, Wang JJ, Cumming RG, et al. Long-term topical timolol and blood lipids: the Blue Mountains Eye Study. J Glaucoma 2000, 9:174-178.
90. Pocock SJ, Shaper AG, Phillips AN Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ 1989, 298:998-1002.
91. Armaly MF Glaucoma. Arch Ophthalmol 1972, 88:439-460.
92. Drance SM Some factors in the production of low tension glaucoma. Br J Ophthalmol 1972, 56:229-242.
93. Klein BE, Klein R Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol 1981, 99:837-839.
94. McGwin G, McNeal S, Owsley C, et al. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 2004, 122:822-826.
95. Schulzer M, Drance SM, Carter CJ, et al. Biostatistical evidence for two distinct chronic open angle glaucoma populations. Br J Ophthalmol 1990, 74:196-200.
96. Wang L, Cioffi GA, Van Buskirk EM The vascular pattern of the optic nerve and its potential relevance in glaucoma. Curr Opin Ophthalmol 1998, 9:24-29.
97. Orgul S, Cioffi GA, Wilson DJ, et al. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci 1996, 37:1860-1869.
98. O'Brien C Vasospasm and glaucoma. Br J Ophthalmol 1998, 82:855-856.
99. Bayer AU, Keller ON, Ferrari F, et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 2002, 133:135-137.
100. Bayer AU, Ferrari F, Erb C High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 2002, 47:165-168.
101. Wilson JM, Jungner YG Principles of mass screening for disease. Bol Oficina Sanit Panam 1968, 64:281-293.
102. Rossetti L, Marchetti N, Orzalsei N, et al. Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?. Arch Ophthalmol 1993, 111:96-103.
103. Sycha T, Vass C, Findl O, et al. Interventions for normal tension glaucoma. Cochrane Database Syst Rev 2003, CD002222.
104. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002, 120:1268-1279.
105. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002, 120:701-713.
106. The Advanced Glaucoma Intervention Study (AGIS) 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 2002, 134:499-512.
107. Grodum K, Heijl A, Bengtsson B A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthalmol Scand 2002, 80:627-631.
108. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991, 134:1102-1110.
109. Harper R, Reeves B The sensitivity and specificity of direct ophthalmoscopic optic disc assessment in screening for glaucoma: a multivariate analysis. Graefes Arch Clin Exp Ophthalmol 2000, 238:949-955.
110. Vitale S, Smith TD, Quigley T, et al. Screening performance of functional and structural measurements of neural damage in open-angle glaucoma: a case-control study from the Baltimore Eye Survey. J Glaucoma 2000, 9:346-356.
111. Allen CS, Sponsel WE, Trigo Y, et al. Comparison of the frequency doubling technology screening algorithm and the Humphrey 24-2 SITA-FAST in a large eye screening. Clin Experiment Ophthalmol 2002, 30:8-14.
112. Kothy P, Vargha P, Hollo G Glaucoma-screening with the Heidelberg Retina Tomograph II. Klin Monatsbl Augenheilkd 2003, 220:540-544.
113. Kalaboukhova L, Lindblom B Frequency doubling technology and high-pass resolution perimetry in glaucoma and ocular hypertension. Acta Ophthalmol Scand 2003, 81:247-252.